Northland Securities Raises Earnings Estimates for AXT

AXT Inc (NASDAQ:AXTI) – Investment analysts at Northland Securities lifted their FY2027 earnings per share estimates for AXT in a research note issued to investors on Thursday, June 25th. Northland Securities analyst T. Savageaux now anticipates that the semiconductor company will earn $0.55 per share for the year, up from their previous forecast of $0.42. The consensus estimate for AXT’s current full-year earnings is $0.20 per share.

Separately, Weiss Ratings raised shares of AXT from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 27th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $43.80.

AXT Stock Performance

AXTI stock opened at $69.06 on Friday. AXT has a 52 week low of $1.85 and a 52 week high of $143.16. The firm’s fifty day moving average is $97.84 and its 200 day moving average is $54.90. The firm has a market cap of $4.52 billion, a P/E ratio of -222.77 and a beta of 1.80.

AXT (NASDAQ:AXTI) last posted its quarterly earnings results on Thursday, April 30th. The semiconductor company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.03. AXT had a negative net margin of 14.69% and a negative return on equity of 5.71%. The firm had revenue of $26.92 million for the quarter, compared to the consensus estimate of $26.22 million. AXT has set its Q2 2026 guidance at 0.060-0.080 EPS.

Insider Buying and Selling

In related news, Director Jesse Chen sold 6,172 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $115.24, for a total transaction of $711,261.28. Following the transaction, the director owned 50,275 shares in the company, valued at $5,793,691. The trade was a 10.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director David C. Chang sold 8,333 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $111.17, for a total value of $926,379.61. Following the transaction, the director directly owned 65,165 shares of the company’s stock, valued at $7,244,393.05. The trade was a 11.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 251,636 shares of company stock valued at $27,789,677 over the last ninety days. 5.97% of the stock is owned by insiders.

Hedge Funds Weigh In On AXT

A number of hedge funds and other institutional investors have recently made changes to their positions in AXTI. American Capital Advisory LLC purchased a new stake in AXT in the first quarter worth $27,000. Kohmann Bosshard Financial Services LLC bought a new position in AXT in the 1st quarter worth $31,000. XTX Topco Ltd bought a new position in AXT in the 2nd quarter worth $42,000. Jefferies Financial Group Inc. purchased a new stake in shares of AXT in the 3rd quarter worth about $52,000. Finally, Leonteq Securities AG purchased a new stake in shares of AXT in the 1st quarter worth about $57,000. Institutional investors own 49.52% of the company’s stock.

About AXT

AXT, Inc (NASDAQ: AXTI) is a global supplier of compound and single-element semiconductor substrates, offering a range of materials critical for high-performance electronic and optoelectronic devices. Founded in 1986 and headquartered in Fremont, California, AXT specializes in the development, manufacture and distribution of wafers composed of gallium arsenide (GaAs), indium phosphide (InP), gallium nitride (GaN) and other compound semiconductor materials. These substrates serve as the foundational platforms for devices used in data communications, wireless infrastructure, advanced computing, consumer electronics and photovoltaic applications.

AXT’s product portfolio encompasses a variety of wafer sizes, dopant concentrations and crystal orientations, tailored to meet the precise specifications of its customers.